Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial.

Yoshikawa T, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Hirabayashi N, Mikata S, Iwahashi M, Fukushima R, Takiguchi N, Miyashiro I, Morita S, Miyashita Y, Tsuburaya A, Sakamoto J.

Ann Surg Oncol. 2014 Jan;21(1):213-9. doi: 10.1245/s10434-013-3055-x. Epub 2013 Jul 10.

PMID:
23838904
2.

A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS).

Yoshikawa T, Tsuburaya A, Morita S, Kodera Y, Ito S, Cho H, Miyashita Y, Sakamoto J.

Jpn J Clin Oncol. 2010 Apr;40(4):369-72. doi: 10.1093/jjco/hyp178. Epub 2010 Mar 18.

3.

Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study.

Yoshikawa T, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Hasegawa S, Aoyama T, Hayashi T, Morita S, Miyashita Y, Tsuburaya A, Sakamoto J.

Ann Surg Oncol. 2014 Jun;21 Suppl 3:S385-9. doi: 10.1245/s10434-014-3615-8. Epub 2014 Mar 5.

PMID:
24595801
4.

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.

Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K, Miyamoto H, Sato Y, Takahashi Y, Katsuki S, Hirayama M, Takahashi M, Ono M, Maeda M, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Hirata K, Kato J.

Cancer Chemother Pharmacol. 2013 Mar;71(3):789-97. doi: 10.1007/s00280-013-2073-5. Epub 2013 Jan 22.

PMID:
23338051
5.

[A phase II prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma].

Huang DZ, Xiong JP, Xu N, Yan Z, Zhuang ZX, Yu Z, Wan HP, Zhang Y, Deng T, Zheng RS, Guo ZQ, Hu CH, Wang ML, Yu ZH, Yao Y, Meng JC, Ba Y.

Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):865-8. doi: 10.3760/cma.j.issn.0253-3766.2012.11.015. Chinese.

PMID:
23291139
6.

Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.

Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, Tanabe K, Takahashi N, Imamura H, Tatsumoto N, Hara A, Nishikawa K, Fukushima R, Nozaki I, Kojima H, Miyashita Y, Oba K, Buyse M, Morita S, Sakamoto J.

Lancet Oncol. 2014 Jul;15(8):886-93. doi: 10.1016/S1470-2045(14)70025-7. Epub 2014 Jun 18.

PMID:
24954805
7.

Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer.

Oki E, Emi Y, Kusumoto T, Sakaguchi Y, Yamamoto M, Sadanaga N, Shimokawa M, Yamanaka T, Saeki H, Morita M, Takahashi I, Hirabayashi N, Sakai K, Orita H, Aishima S, Kakeji Y, Yamaguchi K, Yoshida K, Baba H, Maehara Y.

Ann Surg Oncol. 2014 Jul;21(7):2340-6. doi: 10.1245/s10434-014-3594-9. Epub 2014 Mar 7.

PMID:
24604583
8.

Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.

Feng D, Leong M, Li T, Chen L, Li T.

World J Surg Oncol. 2015 Jan 30;13:11. doi: 10.1186/s12957-015-0444-6.

9.

Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.

Inoue K, Nakane Y, Kogire M, Fujitani K, Kimura Y, Imamura H, Tamura S, Okano S, Kwon AH, Kurokawa Y, Shimokawa T, Takiuchi H, Tsujinaka T, Furukawa H.

Eur J Surg Oncol. 2012 Feb;38(2):143-9. doi: 10.1016/j.ejso.2011.11.009. Epub 2011 Dec 9.

PMID:
22154885
10.

A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomized phase II trial (COMPASS-D trial).

Yoshikawa T, Taguri M, Sakuramoto S, Kunisaki C, Fukunaga T, Ito S, Cho H, Tanabe K, Nishikawa K, Matsui T, Morita S, Tsuburaya A.

Jpn J Clin Oncol. 2012 Jan;42(1):74-7. doi: 10.1093/jjco/hyr166. Epub 2011 Nov 17.

11.

A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.

Okabe H, Hata H, Ueda S, Zaima M, Tokuka A, Yoshimura T, Ota S, Kinjo Y, Yoshimura K, Sakai Y; Kyoto University Surgical Oncology Group (KUSOG).

J Surg Oncol. 2016 Jan;113(1):36-41. doi: 10.1002/jso.24096. Epub 2015 Nov 25.

PMID:
26604064
12.

A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.

Shim HJ, Kim KR, Hwang JE, Bae WK, Ryu SY, Park YK, Nam TK, Chung IJ, Cho SH.

Cancer Chemother Pharmacol. 2016 Mar;77(3):605-12. doi: 10.1007/s00280-016-2973-2. Epub 2016 Feb 5.

PMID:
26846507
13.

Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer.

Mochiki E, Ogata K, Ohno T, Toyomasu Y, Haga N, Fukai Y, Aihara R, Ando H, Uchida N, Asao T, Kuwano H; North Kanto Gastric Cancer Study Group.

Br J Cancer. 2012 Jun 26;107(1):31-6. doi: 10.1038/bjc.2012.222. Epub 2012 May 22.

14.

Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.

Wang X, Wang ML, Zhou LY, Lu XY, Yang JF, Yu HG.

Clin Transl Oncol. 2013 Oct;15(10):836-42. doi: 10.1007/s12094-013-1012-6. Epub 2013 Feb 5.

PMID:
23381898
15.

A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer.

Moriwaki T, Hirai S, Hironaka S, Amagai K, Soeda A, Sato M, Nihei T, Hirose M, Matsuda K, Ohkawara A, Yamaguchi T, Ozeki M, Mamiya T, Murashita T, Hyodo I.

Gastric Cancer. 2014 Apr;17(2):354-61. doi: 10.1007/s10120-013-0284-4. Epub 2013 Jul 13.

PMID:
23852397
16.

[Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].

Yabusaki H, Nashimoto A, Tanaka O.

Gan To Kagaku Ryoho. 2003 Nov;30(12):1933-40. Japanese.

PMID:
14650962
17.

Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer.

Fushida S, Nashimoto A, Fukushima N, Kawachi Y, Fujimura T, Kuwabara S, Musha N; DCS Study Group.

Jpn J Clin Oncol. 2012 Feb;42(2):131-3. doi: 10.1093/jjco/hyr183. Epub 2011 Dec 13.

18.

[A safety analysis in patients treated with oxaliplatin plus S-1 as adjuvant therapy for gastric cancer].

Zhou Y, Huang J, Yang L, Chi Y, Qu T, Lü X, Wang JW.

Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):860-4. doi: 10.3760/cma.j.issn.0253-3766.2012.11.014. Chinese.

PMID:
23291138
19.

[A case of advanced gastric cancer exhibiting pathological complete response after neoadjuvant chemotherapy].

Taniguchi M, Watanabe Y, Shirakawa M, Nakano H, Endo W, Hamano R, Tsujie M, Yano H.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2298-300. Japanese.

PMID:
24394091
20.

Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer.

Kochi M, Fujii M, Kanamori N, Kaiga T, Takahashi T, Kobayashi M, Takayama T.

J Cancer Res Clin Oncol. 2006 Dec;132(12):781-5. Epub 2006 Jun 28.

PMID:
16804723
Items per page

Supplemental Content

Write to the Help Desk